Market close overview
Sweden's main equity gauge finished higher on Tuesday, with sector strength in Healthcare, Telecoms and Financials supporting the rally. At the close in Stockholm the OMX Stockholm 30 was up 0.27%.
Top and bottom performers
The session's leading stock on the OMX Stockholm 30 was AstraZeneca PLC (ST:AZN), which advanced 2.64% - a 48.50 point gain - to finish at 1,886.00. The move brought AstraZeneca to an all-time high during the session.
Other notable winners included Skanska AB ser. B (ST:SKAb), which rose 1.85% or 4.90 points to close at 269.40, and Evolution AB (ST:EVOG), up 1.65% or 8.60 points to 528.80 in late trade.
On the downside, Boliden AB (ST:BOL) recorded the largest loss among the benchmark components, falling 2.78% or 18.00 points to end at 628.40. Epiroc AB Class A (ST:EPIRa) slipped 1.16% or 3.00 points to 255.80, while Sandvik AB (ST:SAND) declined 1.11% or 4.20 points to finish at 372.90.
Market breadth
Despite the headline gain, market breadth was weaker on the day: declining issues on the Stockholm Stock Exchange outnumbered advancing ones by 402 to 322, and 77 listings finished unchanged.
Commodities and currency moves
In commodity markets, crude oil for April delivery fell 1.21% or 0.76 to $61.99 a barrel. Brent oil for April delivery dropped 2.33% or 1.60 to $67.05 a barrel. The April Gold Futures contract declined 3.23% or 163.01 to trade at $4,883.29 a troy ounce.
Currency moves showed both the euro and the US dollar strengthening versus the Swedish krona. EUR/SEK rose 0.62% to 10.65 and USD/SEK increased 0.73% to 9.00. The US Dollar Index Futures was up 0.37% at 97.18.
What the session shows
The close reflects a market where sector-level gains in Healthcare, Telecoms and Financials helped push the benchmark higher while overall participation favored decliners. Commodity prices moved lower and the krona weakened against major currencies by modest margins.